The global myopia & presbyopia eye drops market is expected to record a CAGR of 74.3% during 2021-2028 and was estimated to be valued at US$ 52.7 million in 2021.
R&D of new drugs is expected to propel growth of the global myopia & presbyopia eye drops market over the forecast period. For instance, in September 2020, Visus Therapeutics Inc. initiated a clinical trial for a new eye drop designed for restoring the loss of nearby vision associated with presbyopia.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/4633
Market Opportunities
Funding for R&D is expected to offer lucrative growth opportunities for players in the global myopia & presbyopia eye drops market. For instance, in September 2020, Orasis Pharmaceuticals raised US$ 30 million for R&D of its eye drop drug candidate, CSF-1 for the treatment of presbyopia.
COVID-19 Impact Analysis
Globally, as of 6:02pm CET, 3 February 2022, there have been 383,509,779 confirmed cases of COVID-19, including 5,693,824 deaths, reported to WHO. As of 2 February 2022, a total of 10,040,768,270 vaccine doses have been administered. The COVID-19 pandemic has limited development, production, and supply of eye drops and other drugs. Moreover, the footfall in clinics and health institutions has gone down over 70%.
Market Restraints
Availability of alternative treatments such as modified spectacle prescription, orthokeratology (ortho-k), and bifocal/ multifocal soft contact lenses is expected to hinder growth of the global myopia & presbyopia eye drops market.
Market Trends
Major players operating in the global myopia & presbyopia eye drops market are also focused on R&D to expand their product portfolio. For instance, Eyenovia, Inc., in 2020, received the U.S. Food and Drug Administration’s IND application for MicroLine for improving near vision in patients suffering with presbyopia.
Key Developments
Major players operating in the global myopia & presbyopia eye drops market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in February 2021, Laboratoires Théa acquired NVK-002, a low-dose atropine eye drop, from Nevakar for distribution in Europe.
wn approaches are also used for ensuring the credibility of the valuations and market segments.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4633
Key Players
Major players operating in the global myopia & presbyopia eye drops market include, AbbVie Inc. (Allergan), Eyenovia, Inc., Jawa Pharmaceuticals (India) Pvt. Ltd., LENZ Therapeutics, Novartis AG, Ocuphire Pharma Inc., Orasis Pharmaceuticals, OSRX Pharmaceuticals, Visus Therapeutics, and Vyluma Inc.
Reasons to buy this Myopia & Presbyopia Eye Drops Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Myopia & Presbyopia Eye Drops Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Myopia & Presbyopia Eye Drops Market
◘ Leading company profiles reveal details of key Myopia & Presbyopia Eye Drops Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Myopia & Presbyopia Eye Drops Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Myopia & Presbyopia Eye Drops Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Myopia & Presbyopia Eye Drops Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
https://www.coherentmarketinsights.com/promo/buynow/4633
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Eye Drops
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Industry Trends
- Mergers and Acquisitions
- Technology Overview
- Regulation Scenario
- Key Developments
- Recent Approvals
- PEST Analysis
- Epidemiology
- Pipeline Analysis
- Market Dynamics
- Global Myopia & Presbyopia Eye Drops Market– Impact of Coronavirus (COVID-19) Pandemic
- Impact of COVID-19 on Supply and Demand
- Impact of COVID-19 on Research and Development
- Impact of COVID-19 on Overall Healthcare Market
- Global Myopia & Presbyopia Eye Drops Market, By Eye Drops, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Atropine Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pipeline Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- CSF-1
- AGN-190584
- Nyxol
- UNR844-Cl
- PRX-100
- MicroLine
- Others
- Introduction
- Global Myopia & Presbyopia Eye Drops Market, By Indication, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Myopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Presbyopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Myopia & Presbyopia Eye Drops Market, By End User, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ophthalmic Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Myopia & Presbyopia Eye Drops Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Eye Drops, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries/Region, 2017 – 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Orasis Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie Inc. (Allergan)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OSRX Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- LENZ Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Visus Therapeutics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ocuphire Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Eyenovia, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vyluma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Jawa Pharmaceuticals (India) Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Orasis Pharmaceuticals
- Analyst Views
- Section
- Research Methodology
- About us
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837